• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Advisorshares Psychedelics ETF (NY: PSIL )

    12.32 UNCHANGED
    Streaming Delayed Price Updated: 8:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Advisorshares Psychedelics ETF

    < Previous 1 2 3 4 5 Next >
    Top And Flop ETFs Of The First Half
    In this article, we have highlighted three ETFs each from the best and worst-performing zones in the first half of 2024. 
    Via Talk Markets
    Topics ETFs
    Best And Worst ETF Zones Of Q2
    After the worst monthly decline in many months in April, global stock markets have staged a nice comeback on renewed Fed rate cut bets, ongoing artificial intelligence (AI) developments and strong... 
    Via Talk Markets
    Topics Artificial Intelligence ETFs Economy
    Exposures Artificial Intelligence Interest Rates
    Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
    FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision. 
    Via Benzinga
    Exposures Product Safety
    Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
    Via Benzinga
    Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
    Via Benzinga
    Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
    Via Benzinga
    Mental Health Mavericks: 3 Stocks Changing the Game
    Except for the psychedelics movement, there seem to be very few mental health stocks to buy that are making money. 
    Via InvestorPlace
    Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
    Via Benzinga
    Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
    New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian... 
    Via Benzinga
    Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
    Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD 
    Via Benzinga
    Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
    Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury 
    Via Benzinga
    Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
    President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also... 
    Via Benzinga
    Psychedelic Drug Stocks Index Up In December; Down YTD
    The constituents in the Index are up 9.1% MTD, on average, are down 29.2% YTD, on average, and are now down 85.9% from their highs in 2021. 
    Via Talk Markets
    Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
    Biden To Decide On Psychedelic Therapy Bill 
    Via Benzinga
    Psychedelic Drug Stocks Index Declined 1.6% This Week
    Our Psychedelic Drug Stocks Index is now down 11.5% YTD. The AdvisorShares Psychedelic ETF (PSIL), in comparison, remains down 28.8% YTD. 
    Via Talk Markets
    Topics ETFs
    Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
    John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy 
    Via Benzinga
    5 Largest Psychedelic Compound-Based Drug Stocks Up 3% Last Week
    The 5 constituents in our Psychedelic Drug Stocks Index jumped 30.2%, on average, in November and were up a further 2.8% last week. 
    Via Talk Markets
    Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
    Defense Dept. Funds Ketamine Study For PTSD Treatment  
    Via Benzinga
    Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
    GOP Candidate Vivek Ramaswamy Wants Legal Psychedelics And Cannabis For PTSD In New Veterans Plan 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    GH Research Drags Down Psychedelic Drug Stocks Index By 7%
    The 5 constituents in the Psychedelic Drug Stocks Index continue to exhibit extreme volatility week after week. 
    Via Talk Markets
    Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
    Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans? 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
    DEA Psilocybin Rescheduling Denial Overruled By Federal Appeals Court 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More
    Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted 
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
    Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts 
    Via Benzinga
    Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
    Cybin And Small Pharma Shareholders Green Light Acquisition Resolution 
    Via Benzinga
    Exposures Product Safety
    Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
    Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares 
    Via Benzinga
    Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
    Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of... 
    Via Benzinga
    September Summary: Largest Psychedelic Drug Stocks Dropped 14%
    Seelos Therapeutics' market capitalization dropped below $50M with the recent dramatic decline in its share price and, as such, is no longer part of the Psychedelic Drug Stocks Index. The remaining... 
    Via Talk Markets
    EXCLUSIVE: What's Next For Cannabis? Industry Experts Discuss Game-Changing New Policies
    Cannabis reform has moved one step closer to reality at the federal level on Wednesday, with the Senate Banking Committee approving the Secure and Fair Enforcement Regulation (SAFER) Banking Act. 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.